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Figure S1. Aging-effects KV7 regulation of membrane potential in mesenteric 
arteries 
 
Example of resting membrane potential (upper trace) and contractile force (lower 
trace) in young (A) and old (B) mice. (C) Summarized data of resting membrane 
potential. Membrane potential (upper trace) and contractile force (lower trace) in 
isometric vessel preparation at 3µM methoxamine (ME)–induced tone and after 
subsequent application of 3 µM QO58 and 3 µM XE991 in young (D, E) and old (F, G) 
mice. The microelectrode symbol denotes phases when the microelectrode was 
impaled. Summarized data of contractile force (H) in the presence of 3µM ME, 3 µM 
ME + 3 µM QO58, and ME + QO58 + 3 µM XE991. (Data are mean and SD. (C): 
unpaired t-test n, N=4, for young and old mice; (E,G) *p<0.05. One-way ANOVA test 
with post-hoc Dunn’s multiple comparison test; n=7, N=7 for young, n=5, N=5 for old 
mice, (H) *p<0.05.  young ME vs. young ME + QO58; young ME + QO58 vs young 
ME+ QO58 + XE991; young ME + QO58 vs. old ME + QO58. Two-way ANOVA test 






















Figure S2.  
Figure S2.  Relative expression of KCNQ 1, 3, 4, 5 channels at mRNA levels in 
(–) PVAT mesenteric arteries from young and aged mice normalized to 18s. 
 
(A) Relative mRNA levels for Kcnq1 (N = 3 for young; N = 7 for 12-months old; N = 5 
for 16-months old; N = 3 for 24 months old mice).  
(B) Relative mRNA levels for Kcnq3 (N = 4 for young; N = 8 for 12-months old; N = 5 
for 16-months old; N = 3 for 24-months old mice). 
(C) Relative mRNA levels for Kcnq4 (N = 4 for young; N = 8 for 12-months old; N = 5, 
for 16-months old; N = 3 for 24-months old mice). 
(D) Relative mRNA levels for Kcnq5 (N = 4 for young; N = 8 for 12-months old; N = 5 
for 16-months old; N = 3 for 24-months old mice). ns, P > 0.05, Kruskal–Wallis one-
way analysis of variance. Data are mean and SD. 
Figure S3.  
 
Figure S3.  Age-associated changes in PVAT. Hematoxylin and eosin stain of PVAT around mesenterial arteries and veins of young 
(A and B) and old (C and D) mice. Mean fat cell per perimeter (C) and area (F). Magnification 5x, scale bar=200µm (A and C) and 40x, 
scale bar = 20µm (B and D). Data are mean and SD. *p<0.01, two-sided unpaired t-test. 
 
Figure S4.  
 
 
Figure S4. Ly6B stain (red) of perivascular fat around mesenterial vessels of young (A and B) and old (C and D) mice. Blue 
DAPI, green autofluoresence. Mean number of Ly6b positive cells of two sections (E). Magnification 10x, scale bar = 200µm (A and C) 
and magnification 40x, scale bar= 50 µm (B and D), ***p<0.001, two-sided unpaired t-test.
Table S1. Top upregulated GO Terms and KEGG Pathways in PVAT isolated 
from 12-month old mice 
 
GO Biological Process 
id Terms p. value Adj.p.value 
GO:0002250 adaptive immune response 1.18E-90 6.11E-87 
GO:0051249 regulation of lymphocyte activation 1.52E-75 3.91E-72 
GO:0002764 immune response-regulating signaling pathway 5.80E-75 9.98E-72 
GO:0002757 immune response-activating signal transduction 4.56E-72 5.89E-69 
GO:0050867 positive regulation of cell activation 7.06E-71 7.30E-68 
GO:0098542 defense response to other organism 9.32E-71 8.02E-68 
GO:0002253 activation of immune response 2.83E-70 2.09E-67 
GO:0002696 positive regulation of leukocyte activation 4.29E-69 2.77E-66 
GO:0042113 B cell activation 1.70E-68 9.78E-66 
GO:0002768 
immune response-regulating cell surface 
receptor signaling pathway 6.12E-67 3.16E-64 
GO:0051251 positive regulation of lymphocyte activation 1.54E-66 7.21E-64 
GO:0002429 
immune response-activating cell surface receptor 
signaling pathway 1.36E-64 5.85E-62 
GO:0050851 antigen receptor-mediated signaling pathway 5.76E-64 2.29E-61 
GO:0002460 
adaptive immune response based on somatic 
recombination of immune receptors built from 
immunoglobulin superfamily domains 1.23E-63 4.53E-61 
GO:0002443 leukocyte mediated immunity 2.14E-60 7.36E-58 
GO:0002449 lymphocyte mediated immunity 1.72E-58 5.56E-56 
GO:0050864 regulation of B cell activation 9.82E-57 2.98E-54 
GO:0050853 B cell receptor signaling pathway 6.90E-56 1.98E-53 
GO:0042110 T cell activation 1.30E-51 3.53E-49 
GO:0002250 adaptive immune response 1.18E-90 6.11E-87 
KEGG 
id Terms p. value Adj.p.value 
mmu04060 Cytokine-cytokine receptor interaction 1.35E-24 4.06E-22 
mmu05340 Primary immunodeficiency 7.28E-23 1.09E-20 
mmu04640 Hematopoietic cell lineage 3.45E-22 3.45E-20 
mmu04672 Intestinal immune network for IgA production 2.17E-17 1.62E-15 
mmu04380 Osteoclast differentiation 1.00E-16 6.02E-15 
mmu04658 Th1 and Th2 cell differentiation 1.48E-16 7.42E-15 
mmu05321 Inflammatory bowel disease (IBD) 2.26E-16 9.47E-15 
mmu04064 NF-kappa B signaling pathway 2.52E-16 9.47E-15 
mmu04650 Natural killer cell mediated cytotoxicity 3.40E-16 1.13E-14 
mmu05330 Allograft rejection 1.17E-15 3.51E-14 
mmu04660 T cell receptor signaling pathway 1.47E-15 4.02E-14 
mmu04514 Cell adhesion molecules (CAMs) 1.82E-15 4.56E-14 
mmu04659 Th17 cell differentiation 2.98E-15 6.89E-14 
mmu04662 B cell receptor signaling pathway 3.09E-14 6.62E-13 
mmu05332 Graft-versus-host disease 4.92E-14 9.85E-13 
mmu04061 
Viral protein interaction with cytokine and 
cytokine receptor 6.91E-14 1.30E-12 
mmu05168 Herpes simplex virus 1 infection 6.48E-13 1.14E-11 
mmu04940 Type I diabetes mellitus 2.12E-12 3.53E-11 
mmu05140 Leishmaniasis 3.59E-12 5.67E-11 
mmu04060 Cytokine-cytokine receptor interaction 1.35E-24 4.06E-22 
Table S2. Top downregulated GO Terms and KEGG Pathways in PVAT isolated 
from 12-month old mice 
GO Biological Process 
id Terms p. value Adj.p.value 
GO:0006091 generation of precursor metabolites and energy 7.32E-47 3.48E-43 
GO:0051186 cofactor metabolic process 4.73E-41 1.12E-37 
GO:0022900 electron transport chain 2.51E-39 3.98E-36 
GO:0045333 cellular respiration 9.33E-39 1.11E-35 
GO:0046034 ATP metabolic process 1.84E-36 1.75E-33 
GO:0032787 monocarboxylic acid metabolic process 7.77E-36 6.15E-33 
GO:0015980 
energy derivation by oxidation of organic 
compounds 9.13E-35 6.20E-32 
GO:0009161 
ribonucleoside monophosphate metabolic 
process 4.17E-34 2.48E-31 
GO:0009167 
purine ribonucleoside monophosphate metabolic 
process 6.48E-34 3.42E-31 
GO:0006119 oxidative phosphorylation 7.45E-34 3.54E-31 
GO:0009199 ribonucleoside triphosphate metabolic process 8.44E-34 3.65E-31 
GO:0009126 
purine nucleoside monophosphate metabolic 
process 9.63E-34 3.81E-31 
GO:0009205 
purine ribonucleoside triphosphate metabolic 
process 2.11E-33 7.73E-31 
GO:0009144 purine nucleoside triphosphate metabolic process 3.64E-33 1.23E-30 
GO:0009123 nucleoside monophosphate metabolic process 6.08E-33 1.93E-30 
GO:0022904 respiratory electron transport chain 1.38E-32 4.11E-30 
GO:0009141 nucleoside triphosphate metabolic process 4.63E-32 1.29E-29 
GO:0007005 mitochondrion organization 4.26E-31 1.12E-28 
GO:0042773 ATP synthesis coupled electron transport 1.32E-30 3.30E-28 
GO:0042775 
mitochondrial ATP synthesis coupled electron 
transport 2.14E-30 5.08E-28 
KEGG 
id Terms p. value Adj.p.value 
mmu05012 Parkinson disease 1.23E-41 3.79E-39 
mmu00190 Oxidative phosphorylation 7.22E-41 1.11E-38 
mmu05016 Huntington disease 3.95E-33 3.64E-31 
mmu04932 Non-alcoholic fatty liver disease (NAFLD) 4.74E-33 3.64E-31 
mmu04714 Thermogenesis 1.07E-30 6.59E-29 
mmu01200 Carbon metabolism 9.08E-19 4.64E-17 
mmu01212 Fatty acid metabolism 3.19E-18 1.40E-16 
mmu04723 Retrograde endocannabinoid signaling 8.22E-15 3.16E-13 
mmu04146 Peroxisome 2.66E-11 9.07E-10 
mmu00620 Pyruvate metabolism 3.06E-11 9.40E-10 
mmu03320 PPAR signaling pathway 3.68E-11 1.03E-09 
mmu00020 Citrate cycle (TCA cycle) 2.73E-10 6.99E-09 
mmu00280 Valine, leucine and isoleucine degradation 4.99E-10 1.18E-08 
mmu00010 Glycolysis / Gluconeogenesis 2.95E-09 6.34E-08 
mmu04260 Cardiac muscle contraction 3.10E-09 6.34E-08 
mmu01040 Biosynthesis of unsaturated fatty acids 7.96E-09 1.53E-07 
mmu01230 Biosynthesis of amino acids 4.98E-08 8.99E-07 
mmu00062 Fatty acid elongation 6.78E-08 1.16E-06 
mmu00640 Propanoate metabolism 3.46E-07 5.58E-06 
mmu00900 Terpenoid backbone biosynthesis 5.77E-07 8.86E-06 
 
 




Fgf14 Fibroblast growth factor 14 
Kcne1l Potassium voltage-gated channel subfamily E regulatory beta 
subunit 5 
Kcne2 Potassium voltage-gated channel subfamily E Isk-related subfamily 
2 
Kcne3 Potassium voltage-gated channel subfamily E member 3 
Kcne4 Potassium voltage-gated channel subfamily E member 4 
Nedd4l Neural precursor cell expressed, developmentally down-regulated 
4-like, E3 ubiquitin protein ligase 
Plcb3 phospholipase C, beta 3 
Plcb4 phospholipase C, beta 4 
Plcd4 phospholipase C, delta 4 
Plcxd1 PI-PLC X domain-containing protein 1 
Plcxd2 PI-PLC X domain-containing protein 2 
Plcxd3 Phosphatidylinositol-specific phospholipase C, X domain 
containing 3 
Prkaca protein kinase, cAMP dependent, catalytic, alpha 
Sgk1 Serine/threonine-protein kinase Sgk1 
Slc5a3 Sodium/myo-inositol cotransporter 
Cyp1a1 Cytochrome P450 1A1 
Wisp2 WNT1 inducible signaling pathway protein 2 
Pon1 Paraoxonase 1 
8430408G22 Protein DEPP1 
Apoc1 Apolipoprotein C-I Truncated apolipoprotein C-I 
Csprs Component of Sp100-rs 
Gm15433 predicted pseudogene 15433 
Cd22 CD22 molecule 
Ms4ab Membrane-spanning 4-domains, subfamily A, member 4B 
Ms4a1 Membrane-spanning 4-domains, subfamily A, member 1 
 




Adcy10 Adenylate cyclase type 10 
Prkaca Protein kinase, cAMP dependent, catalytic, alpha 
Ppard Peroxisome proliferator-activated receptor delta 
Rxra Retinoid X receptor alpha 
Rxrg Retinoic acid receptor RXR-gamma 
Ubc Ubiquitin C  
Fabp5 Fatty acid-binding protein 
Plin2 Perilipin-2 
Plin5 Perilipin-5 
Acaa1a Acetyl-Coenzyme A acyltransferase 1A 
Acaa1b Acetyl-Coenzyme A acyltransferase 1B 
Scp2 Sterol carrier protein 2 
Insr Insulin receptor 
Irs3 Insulin receptor substrate 3 
Pik3cb Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit 
beta isoform 
Pik3r2 Phosphatidylinositol 3-kinase regulatory subunit beta 
Srebf1 Sterol regulatory element-binding protein 1 
Eno1 Alpha-enolase 
Pfkl ATP-dependent 6-phosphofructokinase 
Acly ATP citrate lyase 
Cs Citrate synthase 
Aco1 Aconitase 1 
Aco2 Aconitase 2 
Idh3g Isocitrate dehydrogenase 3 (NAD+), gamma 
Suclg1 Succinate-CoA ligase [ADP/GDP-forming] subunit alpha 
Sdha Succinate dehydrogenase complex, subunit A 
Sdhb Succinate dehydrogenase complex, subunit B 
Sdhc Succinate dehydrogenase complex, subunit C 
Mdh1 Malate dehydrogenase 1 
Mdh2 Malate dehydrogenase 2 
Acaca Acetyl-Coenzyme A carboxylase alpha 
Fasn Fatty acid synthase 
Atp5b ATP synthase subunit beta 
Cox4i2 Cytochrome c oxidase subunit 4 isoform 2 
Scd1 Acyl-CoA desaturase 1 
Scd2 Acyl-CoA desaturase 2 
Scd3 Acyl-CoA desaturase 3 
Fads2 Fatty acid desaturase 2 
Elovl5 Elongation of very long-chain fatty acid protein 5 
Elovl6 Elongation of very long-chain fatty acid protein 6 
 
Table S5. Candidates involved in pathways regulating KCNQ channels 
Candidate Effect Reference 
FGF14 Positively regulates 
KCNQ channels 
(1) 




PIP2 Regulates KCNQ channel 
openings  
(Zaydman et al., 2013 
cAMP/PKA Enhance KCNQ currents (3) 
SGK-1 and Nedd4-2 Modulates KCNQ 
channels by SGK-1 
regulation of the activity of 
the ubiquitin ligase 
Nedd4-2 
(4) 
SMIT1 or Slc5a3 Regulates KCNQ channel (5, 6) 
ion selectivity 
Table S6. Significantly dysregulated genes in PVAT (RNA-Seq) and in white 











s from (7)) 
Gene description Expression Process 










Abhd6 Abhd6 Abhydrolase domain 
containing 6  
↓ 
Acaca Acaca Acetyl-Coenzyme A 
carboxylase alpha  
 
↓ 
Acacb Acacb Acetyl-Coenzyme A 
carboxylase beta  
↓ 
Echs1 Echs1 Enoyl-CoA hydratase, 
mitochondrial 
↓ 
Fasn Fasn Fatty acid synthase ↓ 
Gpd2 Gpd2 Pleckstrin homology 
domain-containing family O 
member 1 
↓ 








Gls Gls  Glutaminase kidney 
isoform, mitochondrial 
↑ 
Hk2 Hk2 Hexokinase-2 ↓ 
Mcee Mcee Methylmalonyl-CoA 
epimerase, mitochondrial 
↓ 
Pdhb Pdhb Pyruvate dehydrogenase 
E1 component subunit 
beta, mitochondrial   
↓ 
Pgk1 Pgk1 Phosphoglycerate kinase 1 ↓ 
Gpt2 Gpt2 Glutamic pyruvate 
transaminase 
↓ 
Hk3 Hk3 Hexokinase-3 ↑ 
Cox5b  Cytochrome c oxidase 


















Cytochrome c oxidase 
subunit 6B1 
↓ 
Cox6c Cox6c Cytochrome c oxidase 







[ubiquinone] 1 alpha 







[ubiquinone] 1 alpha 
↓ 













[ubiquinone] 1 alpha 







[ubiquinone] 1 alpha 







[ubiquinone] 1 alpha 







[ubiquinone] 1 alpha 







[ubiquinone] 1 alpha 
subcomplex subunit 10 
↓ 
Ndufa11 Ndufa11 NADH dehydrogenase 
[ubiquinone] 1 alpha 







[ubiquinone] 1 alpha 







[ubiquinone] 1 beta 







[ubiquinone] 1 beta 
subcomplex subunit 10 
↓ 
Ndufb11 Ndufb11 NADH dehydrogenase 
[ubiquinone] 1 beta 
subcomplex subunit 11 
↓ 




















Ndufv1 Ndufv1 NADH dehydrogenase 
[ubiquinone] flavoprotein 1 
↓ 
Ndufv2 Ndufv2 NADH dehydrogenase 








sulfur polypeptide 1 
↓ 
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